Molecular mechanism of curcumin on the suppression of cholesterol accumulation in macrophage foam cells and atherosclerosis

Molecular Nutrition and Food Research

Volumn 56, Issue 5, 2012, Pages 691-701

  Zhao, Jing Feng ^a   Ching, Li Chieh ^a   Huang, Yu Chu ^a   Chen, Chien Yu ^a   Chiang, An Na ^a   Kou, Yu Ru ^a   Shyue, Song Kun ^b   Lee, Tzong Shyuan ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

Author keywords

ABCA1; Calpain; Curcumin; LXR SR A

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER A1; ABCG1 PROTEIN, MOUSE; APOLIPOPROTEIN A1; APOLIPOPROTEIN E; CALMODULIN; CALPAIN; CD36 ANTIGEN; CHOLESTEROL; CURCUMIN; HYPOCHOLESTEROLEMIC AGENT; LIPOPROTEIN; LIVER X RECEPTOR; LOW DENSITY LIPOPROTEIN; ORPHAN NUCLEAR RECEPTOR; OXIDIZED LOW DENSITY LIPOPROTEIN; PROTEASOME; SCARB1 PROTEIN, MOUSE; SCAVENGER RECEPTOR A; SCAVENGER RECEPTOR B;

ANIMAL; ARTICLE; ATHEROSCLEROSIS; DRUG EFFECT; FOAM CELL; GENETICS; LIPID METABOLISM; METABOLISM; MOUSE; MOUSE MUTANT;

ANIMALS; ANTICHOLESTEREMIC AGENTS; ANTIGENS, CD36; APOLIPOPROTEIN A-I; APOLIPOPROTEINS E; ATHEROSCLEROSIS; ATP-BINDING CASSETTE TRANSPORTERS; CALMODULIN; CALPAIN; CHOLESTEROL; CURCUMIN; FOAM CELLS; LIPID METABOLISM; LIPOPROTEINS; LIPOPROTEINS, LDL; MICE; MICE, MUTANT STRAINS; ORPHAN NUCLEAR RECEPTORS; PROTEASOME ENDOPEPTIDASE COMPLEX; SCAVENGER RECEPTORS, CLASS A; SCAVENGER RECEPTORS, CLASS B;

CURCUMA LONGA; MUS;

EID: 84861653908     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201100735     Document Type: Article

References (50)

1. Glass, C. K., Witztum, J. L., Atherosclerosis. The road ahead. Cell 2001, 104, 503-516.
2. Lusis, A. J., Atherosclerosis. Nature 2000, 407, 233-241.
3. Berliner, J. A., Heinecke, J. W., The role of oxidized lipoproteins in atherogenesis. Free Radic. Biol. Med. 1996, 20, 707-727.
4. Kleemann, R., Zadelaar, S., Kooistra, T., Cytokines and atherosclerosis: a comprehensive review of studies in mice. Cardiovasc. Res. 2008, 79, 360-376.
5. Li, A. C., Glass, C. K., The macrophage foam cell as a target for therapeutic intervention. Nat. Med. 2002, 8, 1235-1242.
6. Collot-Teixeira, S., Martin, J., McDermott-Roe, C., Poston, R., McGregor, J. L. CD36 and macrophages in atherosclerosis. Cardiovasc. Res. 2007, 75, 468-477.
7. Kunjathoor, V. V., Febbraio, M., Podrez, E. A., Moore, K. J. et al., Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages. J. Biol. Chem. 2002, 277, 49982-49988.
8. Cheng, L. C., Su, K. H., Kou, Y. R., Shyue, S. K. et al., α-Lipoic acid ameliorates foam cell formation via liver X receptor α-dependent upregulation of ATP-binding cassette transporters A1 and G1. Free Radic. Biol. Med. 2011, 50, 47-54.
9. Ji, A., Meyer, J. M., Cai, L., Akinmusire, A. et al., Scavenger receptor SR-BI in macrophage lipid metabolism. Atherosclerosis 2011, 217, 106-112.
10. Chen, C. Y., Shyue, S. K., Ching, L. C., Su, K. H. et al., Wogonin promotes cholesterol efflux by increasing protein phosphatase 2B-dependent dephosphorylation at ATP-binding cassette transporter-A1 in macrophages. J. Nutr. Biochem. 2011, 22, 1015-1021.
11. Lu, K. Y., Ching, L. C., Su, K. H., Yu, Y. B. et al., Erythropoietin suppresses the formation of macrophage foam cells: role of liver X receptor α. Circulation 2010, 121, 1828-1837.
12. Rao, C. V., Rivenson, A., Simi, B., Reddy, B. S., Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound. Cancer Res. 1995, 55, 259-266.
13. Wu, J. C., Lai, C. S., Badmaev, V., Nagabhushanam, K. et al., Tetrahydrocurcumin, a major metabolite of curcumin, induced autophagic cell death through coordinative modulation of PI3K/Akt-mTOR and MAPK signaling pathways in human leukemia HL-60 cells. Mol. Nutr. Food Res. 2011, 55, 1646-1654.
14. Chung, L. C., Tsui, K. H., Feng, T. H., Lee, S. L. et al., Curcumin provides potential protection against the activation of hypoxia and prolyl 4-hydroxylase inhibitors on prostate-specific antigen expression in human prostate carcinoma cells. Mol. Nutr. Food Res. 2011, 55, 1666-1676.
15. Villegas, I., Sánchez-Fidalgo, S., de la Lastra, C. A., Chemopreventive effect of dietary curcumin on inflammation-induced colorectal carcinogenesis in mice. Mol. Nutr. Food Res. 2011, 55, 259-267.
16. Conney, A. H., Lysz, T., Ferraro, T., Abidi, T. F. et al., Inhibitory effect of curcumin and some related dietary compounds on tumor promotion and arachidonic acid metabolism in mouse skin. Adv. Enzyme Regul. 1991, 31, 385-396.
17. Rao, C. V., Rivenson, A., Simi, B., Reddy, B. S., Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound. Cancer Res. 1995, 55, 259-266.
18. Strimpakos, A. S., Sharma, R. A., Curcumin: preventive and therapeutic properties in laboratory studies and clinical trials. Antioxid. Redox. Signal. 2008, 10, 511-545.
19. Wongcharoen, W., Phrommintikul, A., The protective role of curcumin in cardiovascular diseases. Int. J. Cardiol. 2009, 133, 145-151.
20. Seo, K. I., Choi, M. S., Jung, U. J., Kim, H. J. et al., Effect of curcumin supplementation on blood glucose, plasma insulin, and glucose homeostasis related enzyme activities in diabetic db/db mice. Mol. Nutr. Food Res. 2008, 52, 995-1004.
21. Olszanecki, R., Jawień, J., Gajda, M., Mateuszuk, L. et al., Effect of curcumin on atherosclerosis in apoE/LDLR-double knockout mice. J. Physiol. Pharmacol. 2005, 56, 627-635.
22. Forman, B. M., Ruan, B., Chen, J., Schroepfer, G. J. Jr. et al., The orphan nuclear receptor LXRα is positively and negatively regulated by distinct products of mevalonate metabolism. Proc. Natl. Acad. Sci. USA 1997, 94, 10588-10593.
23. Hori, N., Hayashi, H., Sugiyama, Y., Calpain-mediated cleavage negatively regulates the expression level of ABCG1. Atherosclerosis 2011, 215, 383-391.
24. Goodarzi, M. O., Taylor, K. D., Jones, M. R., Fang, B. et al., Replication of calpain-10 genetic association with carotid intima-media thickness. Atherosclerosis 2009, 205, 503-505.
25. Chapman, E., Fry, A. N., Kang, M., The complexities of p97 function in health and disease. Mol. Biosyst. 2011, 7, 700-710.
26. Tanaka, A., Cleland, M. M., Xu, S., Narendra, D. P. et al., Proteasome and p97 mediate mitophagy and degradation of mitofusins induced by Parkin. J. Cell. Biol. 2010, 191, 1367-1380.
27. Kim, A. N., Jeon, W. K., Lee, J. J, Kim, B. C., Up-regulation of heme oxygenase-1 expression through CaMKII-ERK1/2-Nrf2 signaling mediates the anti-inflammatory effect of bisdemethoxycurcumin in LPS-stimulated macrophages. Free Radic. Biol. Med. 2010, 49, 323-331.
28. Nakashima, Y., Plump, A. S., Raines, E. W., Breslow, J. L. et al., ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler. Thromb. 1994, 14, 133-140.
29. Reddick, R. L., Zhang, S. H., Maeda, N., Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression. Arterioscler. Thromb. 1994, 14, 141-147.
30. Shi, W., Wang, N. J., Shih, D. M., Sun, V. Z. et al., Determinants of atherosclerosis susceptibility in the C3H and C57BL/6 mouse model: evidence for involvement of endothelial cells but not blood cells or cholesterol metabolism. Circ. Res. 2000, 86, 1078-1084.
31. Suzuki, H., Kurihara, Y., Takeya, M., Kamada, N. et al., A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature 1997, 386, 292-296.
32. Tsai, J. Y., Su, K. H., Shyue, S. K., Kou, Y. R. et al., EGb761 ameliorates the formation of foam cells by regulating the expression of SR-A and ABCA1: role of haem oxygenase-1. Cardiovasc. Res. 2010, 88, 415-423.
33. Zhang, Y., Luo, Z., Ma, L., Xu, Q. et al., Resveratrol prevents the impairment of advanced glycosylation end products (AGE) on macrophage lipid homeostasis by suppressing the receptor for AGE via peroxisome proliferator-activated receptor gamma activation. Int. J. Mol. Med. 2010, 25, 729-734.
34. Brooks-Wilson, A., Marcil, M., Clee, S. M., Zhang, L. H. et al., Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat. Genet. 1999, 22, 336-345.
35. Joyce, C. W., Amar, M. J., Lambert, G., Vaisman, B. L. et al., The ATP binding cassette transporter A1 (ABCA1) modulates the development of aortic atherosclerosis in C57BL/6 and apoE-knockout mice. Proc. Natl. Acad. Sci. USA 2002, 99, 407-412.
36. Arakawa, R., Yokoyama, S., Helical apolipoproteins stabilize ATP-binding cassette transporter A1 by protecting it from thiol protease-mediated degradation. J. Biol. Chem. 2002, 277, 22426-22429.
37. Wang, N., Chen, W., Linsel-Nitschke, P., Martinez, L. O. et al., A PEST sequence in ABCA1 regulates degradation by calpain protease and stabilization of ABCA1 by apoA-I. J. Clin. Invest. 2003, 111, 99-107.
38. Lee, T. S., Lin, C. Y., Tsai, J. Y., Wu, Y. L. et al., Resistin increases lipid accumulation by affecting class A scavenger receptor, CD36 and ATP-binding cassette transporter-A1 in macrophages. Life Sci. 2009, 84, 97-104.
39. Wang, Y., Oram, J. F., Unsaturated fatty acids phosphorylate and destabilize ABCA1 through a phospholipase D2 pathway. J. Biol. Chem. 2005, 280, 35896-36903.
40. Martinez, L. O., Agerholm-Larsen, B., Wang, N., Chen, W. et al., Phosphorylation of a pest sequence in ABCA1 promotes calpain degradation and is reversed by ApoA-I. J. Biol. Chem. 2003, 278, 37368-37374.
41. Arakawa, R., Tsujita, M., Iwamoto, N., Ito-Ohsumi, C. et al., Pharmacological inhibition of ABCA1 degradation increases HDL biogenesis and exhibits antiatherogenesis. J. Lipid Res. 2009, 50, 2299-2305.
42. Choi, J., Husain, M., Calmodulin-mediated cell cycle regulation: new mechanisms for old observations. Cell Cycle 2006, 5, 2183-2186.
43. Iwamoto, N., Lu, R., Tanaka, N., Abe-Dohmae, S. et al., Calmodulin interacts with ATP binding cassette transporter A1 to protect from calpain-mediated degradation and upregulates high-density lipoprotein generation. Arterioscler. Thromb. Vasc. Biol. 2010, 30, 1446-1452.
44. Juan, S. H., Lee, T. S., Tseng, K. W., Liou, J. Y. et al., Adenovirus-mediated heme oxygenase-1 gene transfer inhibits the development of atherosclerosis in apolipoprotein E-deficient mice. Circulation 2001, 104, 1519-1525.
45. Orozco, L. D., Kapturczak, M. H., Barajas, B., Wang, X. et al., Heme oxygenase-1 expression in macrophages plays a beneficial role in atherosclerosis. Circ. Res. 2007, 100, 1703-1711.
46. Yuan, H. Y., Kuang, S. Y., Zheng, X., Ling, H. Y. et al., Curcumin inhibits cellular cholesterol accumulation by regulating SREBP-1/caveolin-1 signaling pathway in vascular smooth muscle cells. Acta Pharmacol. Sin. 2008, 29, 555-563.
47. Asai, A., Miyazawa, T., Dietary curcuminoids prevent high-fat diet-induced lipid accumulation in rat liver and epididymal adipose tissue. J. Nutr. 2001, 131, 2932-2935.
48. Weisberg, S. P., Leibel, R., Tortoriello, D. V., Dietary curcumin significantly improves obesity-associated inflammation and diabetes in mouse models of diabesity. Endocrinology 2008, 149, 3549-3558.
49. Kumar, P., Malhotra, P., Ma, K., Singla, A. et al., SREBP2 mediates the modulation of intestinal NPC1L1 expression by curcumin. Am. J. Physiol. Gastrointest. Liver Physiol. 2011, 301, G148-G155.
50. Shin, S. K., Ha, T. Y., McGregor, R. A., Choi, M. S., Long-term curcumin administration protects against atherosclerosis via hepatic regulation of lipoprotein cholesterol metabolism. Mol. Nutr. Food Res. 2011, 55, 1829-1840.